The first AI-based Chatbot to promote HIV self-management: A mixed methods usability study.

IF 2.8 3区 医学 Q2 INFECTIOUS DISEASES
HIV Medicine Pub Date : 2024-10-10 DOI:10.1111/hiv.13720
Yuanchao Ma, Sofiane Achiche, Gavin Tu, Serge Vicente, David Lessard, Kim Engler, Benoît Lemire, Moustafa Laymouna, Alexandra de Pokomandy, Joseph Cox, Bertrand Lebouché
{"title":"The first AI-based Chatbot to promote HIV self-management: A mixed methods usability study.","authors":"Yuanchao Ma, Sofiane Achiche, Gavin Tu, Serge Vicente, David Lessard, Kim Engler, Benoît Lemire, Moustafa Laymouna, Alexandra de Pokomandy, Joseph Cox, Bertrand Lebouché","doi":"10.1111/hiv.13720","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We developed MARVIN, an artificial intelligence (AI)-based chatbot that provides 24/7 expert-validated information on self-management-related topics for people with HIV. This study assessed (1) the feasibility of using MARVIN, (2) its usability and acceptability, and (3) four usability subconstructs (perceived ease of use, perceived usefulness, attitude towards use, and behavioural intention to use).</p><p><strong>Methods: </strong>In a mixed-methods study conducted at the McGill University Health Centre, enrolled participants were asked to have 20 conversations within 3 weeks with MARVIN on predetermined topics and to complete a usability questionnaire. Feasibility, usability, acceptability, and usability subconstructs were examined against predetermined success thresholds. Qualitatively, randomly selected participants were invited to semi-structured focus groups/interviews to discuss their experiences with MARVIN. Barriers and facilitators were identified according to the four usability subconstructs.</p><p><strong>Results: </strong>From March 2021 to April 2022, 28 participants were surveyed after a 3-week testing period, and nine were interviewed. Study retention was 70% (28/40). Mean usability exceeded the threshold (69.9/68), whereas mean acceptability was very close to target (23.8/24). Ratings of attitude towards MARVIN's use were positive (+14%), with the remaining subconstructs exceeding the target (5/7). Facilitators included MARVIN's reliable and useful real-time information support, its easy accessibility, provision of convivial conversations, confidentiality, and perception as being emotionally safe. However, MARVIN's limited comprehension and the use of Facebook as an implementation platform were identified as barriers, along with the need for more conversation topics and new features (e.g., memorization).</p><p><strong>Conclusions: </strong>The study demonstrated MARVIN's global usability. Our findings show its potential for HIV self-management and provide direction for further development.</p>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2024-10-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/hiv.13720","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Background: We developed MARVIN, an artificial intelligence (AI)-based chatbot that provides 24/7 expert-validated information on self-management-related topics for people with HIV. This study assessed (1) the feasibility of using MARVIN, (2) its usability and acceptability, and (3) four usability subconstructs (perceived ease of use, perceived usefulness, attitude towards use, and behavioural intention to use).

Methods: In a mixed-methods study conducted at the McGill University Health Centre, enrolled participants were asked to have 20 conversations within 3 weeks with MARVIN on predetermined topics and to complete a usability questionnaire. Feasibility, usability, acceptability, and usability subconstructs were examined against predetermined success thresholds. Qualitatively, randomly selected participants were invited to semi-structured focus groups/interviews to discuss their experiences with MARVIN. Barriers and facilitators were identified according to the four usability subconstructs.

Results: From March 2021 to April 2022, 28 participants were surveyed after a 3-week testing period, and nine were interviewed. Study retention was 70% (28/40). Mean usability exceeded the threshold (69.9/68), whereas mean acceptability was very close to target (23.8/24). Ratings of attitude towards MARVIN's use were positive (+14%), with the remaining subconstructs exceeding the target (5/7). Facilitators included MARVIN's reliable and useful real-time information support, its easy accessibility, provision of convivial conversations, confidentiality, and perception as being emotionally safe. However, MARVIN's limited comprehension and the use of Facebook as an implementation platform were identified as barriers, along with the need for more conversation topics and new features (e.g., memorization).

Conclusions: The study demonstrated MARVIN's global usability. Our findings show its potential for HIV self-management and provide direction for further development.

首个促进艾滋病自我管理的人工智能聊天机器人:混合方法可用性研究。
背景:我们开发了一个基于人工智能(AI)的聊天机器人MARVIN,它能全天候为HIV感染者提供经专家验证的自我管理相关信息。本研究评估了(1)使用 MARVIN 的可行性,(2)其可用性和可接受性,以及(3)四个可用性子结构(感知易用性、感知有用性、使用态度和使用行为意向):在麦吉尔大学健康中心进行的一项混合方法研究中,要求注册参与者在 3 周内就预定主题与 MARVIN 进行 20 次对话,并填写一份可用性问卷。根据预先确定的成功阈值对可行性、可用性、可接受性和可用性子结构进行了检查。在定性方面,我们邀请随机抽取的参与者参加半结构化焦点小组/访谈,讨论他们使用 MARVIN 的经验。根据四个可用性子结构确定了障碍和促进因素:从 2021 年 3 月到 2022 年 4 月,28 名参与者在 3 周测试期后接受了调查,9 人接受了访谈。研究保留率为 70%(28/40)。平均可用性超过了临界值(69.9/68),而平均可接受性非常接近目标值(23.8/24)。对 MARVIN 使用态度的评分是积极的(+14%),其余子结构均超过目标值(5/7)。促进因素包括:MARVIN 提供可靠、有用的实时信息支持,易于访问,提供愉快的对话,保密性,以及情感安全感。然而,MARVIN 的理解能力有限和使用 Facebook 作为实施平台,以及需要更多的对话主题和新功能(如记忆)被认为是障碍:本研究证明了 MARVIN 在全球范围内的可用性。我们的研究结果表明了 MARVIN 在艾滋病自我管理方面的潜力,并为进一步发展提供了方向。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
HIV Medicine
HIV Medicine 医学-传染病学
CiteScore
5.10
自引率
10.00%
发文量
167
审稿时长
6-12 weeks
期刊介绍: HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV Medicine, embracing clinical, pharmocological, epidemiological, ethical, preclinical and in vitro studies. In addition, the journal will commission reviews and other feature articles. It will focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS. The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信